جهت دسترسی به کاربرگه ی زیر، از این لینک استفاده کنید. http://78.39.227.9/handle/Hannan/95345
Full metadata record
DC FieldValueLanguage
dc.contributorVermeire, Séverineen_US
dc.contributorSchreiber, Stefanen_US
dc.contributorPetryka, Roberten_US
dc.contributorKuehbacher, Tanjaen_US
dc.contributorHebuterne, Xavieren_US
dc.contributorRoblin, Xavieren_US
dc.contributorKlopocka, Mariaen_US
dc.contributorGoldis, Adrianen_US
dc.contributorWisniewska-Jarosinska, Mariaen_US
dc.contributorBaranovsky, Andreyen_US
dc.contributorSike, Roberten_US
dc.contributorStoyanova, Kremenaen_US
dc.contributorTasset, Chantalen_US
dc.contributorVan der Aa, Annegreten_US
dc.contributorHaren_US
dc.date.accessioned2013en_US
dc.date.accessioned2017-02-11T10:04:55Z-
dc.date.available2017-02-11T10:04:55Z-
dc.date.issued2017en_US
dc.identifier.issnen_US
dc.identifier.other10.1016/S0140-6736(16)32537-5en_US
dc.identifier.urihttp://linkinghub.elsevier.com/retrieve/pii/S0140673616325375en_US
dc.identifier.urihttp://78.39.227.9/handle/Hannan/95345-
dc.description.abstracten_US
dc.format.extentVOLUME : 389en_US
dc.publisheren_US
dc.relation.haspart2017 Lancet Volume 389 Issue 10066 January (13).pdfen_US
dc.subjecten_US
dc.titleClinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trialen_US
dc.typeArticleen_US
dc.journal.volumeVolume 389en_US
dc.journal.issueIssue 10066en_US
dc.journal.monthJanuaryen_US
dc.journal.titleLanceten_US
Appears in Collections:2017

Files in This Item:
File Description SizeFormat 
2017 Lancet Volume 389 Issue 10066 January (13).pdf422.82 kBAdobe PDFThumbnail
Preview File    Request a copy


تمامی کاربرگه ها در کتابخانه ی دیجیتال حنان به صورت کامل محافظت می شوند.